XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK COMPENSATION STOCK COMPENSATION
As of June 30, 2023, there were 618,812 shares available for the grant of awards under the Company's Amended and Restated 2000 Long Term Incentive Plan (Plan), assuming maximum performance of performance-based awards.
Option Awards
A summary of the Company’s stock option activity and related information for the six months ended June 30, 2023 is as follows:
OptionsWeighted-
average
exercise price
Weighted-
average
remaining
contractual
life (years)
Aggregate
intrinsic
value
(in thousands)
Options outstanding, January 1, 2023
1,065,750 $13.66 
Grants50,000 5.92 
Cancellations(4,375)11.27 
Expirations(107,875)13.17 
Options outstanding, June 30, 2023
1,003,500 13.34 4.6$— 
Options exercisable, June 30, 2023
887,875 $13.87 4.0$— 
Total unrecognized stock option expense remaining (in thousands)$450 
Weighted-average years expected to be recognized over1.9
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their stock options on June 30, 2023. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company’s common stock on June 30, 2023 and the exercise price.
On March 8, 2023, the exercise period for the Executive Chairman’s outstanding vested stock options were extended to remain exercisable until ninety days following termination of his service on the Company's Board of Directors (the "Board"). The outstanding stock options remain subject to original expiration dates of such awards. The Company recorded $0.1 million of stock compensation expense in connection with this extension during the three months ended March 31, 2023.
Restricted Stock
A summary of the Company’s restricted stock activity and related information for the six months ended June 30, 2023 is as follows:
Restricted
Shares
Weighted-
average grant
date fair
value
Non-vested restricted shares, January 1, 2023
484,143 $11.79 
Grants333,300 5.37 
Vested(212,037)11.20 
Cancellations(6,783)11.07 
Non-vested restricted shares, June 30, 2023
598,623 $8.44 
Total unrecognized compensation expense remaining (in thousands)$4,553 
Weighted-average years expected to be recognized over1.7
The total fair value of restricted stock that vested during the six months ended June 30, 2023 was $1.2 million.
Performance shares
Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The shares are subject to the terms and conditions of the Company’s Plan.
A summary of the Company’s performance-based award activity and related information for the six months ended June 30, 2023 is as follows:
Performance-
based stock
awards (1)
Weighted-
average grant
date fair
value
Non-vested performance-based awards, January 1, 2023
400,302 $11.56 
Grants191,075 5.92 
Achieved performance over target (2)
16,942 6.36 
Vested(119,739)6.36 
Cancellations(858)14.18 
Non-vested performance-based awards, June 30, 2023
487,722 $10.44 
Total unrecognized compensation expense remaining (in thousands)(3)
$1,390 
Weighted-average years expected to be recognized over2.0
(1)Represents the target number of shares to be issued for each performance-based award.
(2)Represents the number of shares earned over target for performance-based awards granted in 2020 based on performance goals attained. These awards vested in the six months ended June 30, 2023.
(3)The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.
The total fair value of performance-based awards that vested during the six months ended June 30, 2023 was $0.7 million.
Cash-settled performance-based awards
Each cash-settled performance-based award represents the right to receive up to 150% of the target number of deferred stock units with payment in cash equivalent to the value of one share of the Company's common stock. The number of deferred stock units earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The cash-settled performance-based awards are subject to the terms and conditions of the Company’s Plan.
A summary of the Company’s cash-settled performance-based awards activity and related information for the six months ended June 30, 2023 is as follows:
Cash-settled performance-based awards (1)
Weighted-
average fair
value
Non-vested cash-settled performance-based awards, January 1, 2023
85,776 $7.59 
Cancellations(1,790)5.65 
Non-vested cash-settled performance-based awards, June 30, 2023
83,986 $5.65 
Total unrecognized compensation expense remaining (in thousands)(2)
$— 
Weighted-average years expected to be recognized over0.0
(1) Represents the target number of units to be settled in cash.
(2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards.
The Company recorded stock compensation expense as follows (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
Stock Compensation Expense Components2023202220232022
Equity based stock option expense$50 $93 $179 $180 
Restricted and performance-based stock awards expense960 1,187 1,697 2,251 
Stock compensation expense for equity based awards$1,010 $1,280 $1,876 $2,431 
Liability based stock option expense(1)(4)(6)
Cash-settled performance-based awards expense— 86 114 
Total Stock Compensation Expense$1,011 $1,365 $1,872 $2,539